Schedule I controlled substances

This procedure is called chloromethylation and will not only turn 1,3-benzodioxole into a methyl chloride but will work equally well in converting plain old benzene into benzyl chloride. Both are important stepping stones towards the production of X and meth. For example, benzyl chloride is a schedule I controlled substance because it will beget benzaldehyde and phenylacetonitrile (a precursor for phenylacetic acid). 

GHB has been used both for legitimate clinical and chnical research purposes and for a range of iUicit purposes. It was marketed legally in the United States until 1990, when the U.S. Food and Drug Administration (FDA) banned its sale to consumers. Except for the one indication described later in this section, GHB is a Schedule I controlled substance without other FDA-approved indications. The FDA has also declared y-butyrolactone (GBL) as a List I chemical and 1,4-butanediol (1,4-BD) as a Class I health hazard, practically designating these GHB precursors, which are also industrial solvents, as illicit and unapproved new drugs (National Institute on Drug Abuse 2000). 

In 2000, the FDA classified GHB as a Schedule I controlled substance. Punishment for possession, sale, or use of GHB became as severe as for other Schedule I drugs, including up to 20 years in prison. However, GHB was also subclassified as a Schedule III controlled substance, allowing for its medical use in patients with narcolepsy (see box on page 50). 

On February 18, 2000, the Hillary Farias and Samantha Reed Date-Rape Prohibition Act (Public Law 106-172) made the GHB precursor GBL a List I chemical, subject to the criminal, civil, and administrative sanctions of the Controlled Substances Act. On March 13, 2000, GHB became a Schedule I controlled substance (65 FR 13235-13238), subject to the regulatory controls and the criminal, civil, and administrative sanctions of the Controlled Substances Act. Schedule I, which is the same as for heroin, LSD, and marijuana, states that the drug has no medical use and cannot be prescribed, and that the drug has a high potential for abuse. 

GHB is a Schedule I controlled substance according to the Controlled Substances Act. As such, it is unlawful for any person knowingly or intentionally to manufacture, distribute, or dispense GHB, or to possess with intent to manufacture, distribute, or dispense GHB. The penalty for manufacturing or distribution of GHB includes sentencing individuals to 20 or more years in jail and a large fine. 

By 1972, luding out —taking methaqualone with wine—was popular on college campuses. Excessive use of the drug leads to tolerance, dependence, and withdrawal symptoms similar to those of barbiturates. Overdose by methaqualone is more difficult to treat than barbiturate overdose, and deaths have frequently occurred. In the United States, the marketing of methaqualone pharmaceutical products was discontinued in 1984, and the drug became a Schedule I controlled substance. However, some level of occasional abuse has continued. 

NORML petitioned the DEA to reclassify marijuana, but was again denied. Today, marijuana remains a Schedule I controlled substance. Despite the threat of arrest for using an illegal drug, many people who suffer debilitating illnesses use marijuana medicinally today. 

Consulting the Controlled Substance Staff on INDs and Protocols That Use Schedule I Controlled Substances and Drugs (Issued May 8, 2003)... 

The law made GHB a Schedule I controlled substance, which means that it has a high potential for abuse. The act makes it a crime to possess nonmedical GHB and imposes stiff penalties for selling the drug. If someone is caught with GHB in his or her possession, the person may be sentenced to a year in prison and a fine of 1,000. If a person is convicted of selling or providing GHB to someone else, he or she may be sentenced to up to 20 years in prison. In addition, if someone dies because of GHB, the person who gave it to him or her can receive the death penalty. 

Safrole is the 1 starting material for making X today. As a pure chemical it is a schedule I controlled substance and, obviously, is illegal to own or buy without a permit. 

Those drugs with a high potential for abuse, with no currently accepted medical use in treatment in the United States and no accepted information on the safety of their use, even under medical supervision. Research is allowed for Schedule I controlled substances provided the entity is registered with DBA as a researcher. 

Ordering Schedule I controlled substances is done utilizing what form ... 

A representative of fluorinated diazines, Afloqualone (11), was launched in 1983 in Japan as a central acting muscle relaxant [198], It is an analogue of Methaqualone (234) (Fig. 7) - a drug widely used as a hypnotic, for the treatment of insomnia, and as a sedative and muscle relaxant in 1970s, but reclassified as a Schedule I controlled substance in USA in 1984 [199],... 

---